A key advantage of a newly developed deep learning model based on mammogram images is that it doesn’t require additional history or medical record data, which could help boost uptake.
One AI tool enables rapid assessment of coronary artery disease location and severity; another telehealth service focuses on ...
Is age assurance fair for everyone? This is the question raised by a new analysis of Australia’s Age Assurance Technology ...
It can narrow anyone’s view, not being able to see the other, creating a digital divide that is not only generational but ideological, created by the isolation of people and the tribalization of ...
The deployment of technologies such as AI, big data and blockchain is leading toward enhanced grid management.
A research team from the Anhui Institute of Optics and Fine Mechanics (AIOFM), the Hefei Institutes of Physical Science of ...
Heartflow (Nasdaq:HTFL) announced that it received FDA 510(k) clearance for its next-generation Heartflow Plaque Analysis ...
A newly issued manual foreshadows the coming difficult relations that may arise between companies and 'platform workers' – as ...
Heartflow Inc. hasn’t skipped a beat in pumping out good news, with U.S. FDA 510(k) clearance for its next-gen plaque analysis algorithm and platform and Cigna coverage across all lines of coverage ...
Much of this stems from commentary that omits a crucial fact: psycho-legal work by industrial and organisational ...
Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it has received U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results